The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus

dc.contributor.author	Firneisz, Gábor
dc.contributor.author	Rosta, Klára
dc.contributor.author	Al-Aissa, Zahra
dc.contributor.author	Hadarits, Orsolya
dc.contributor.author	Harreiter Jürgen
dc.contributor.author	Nádasdi, Ákos
dc.contributor.author	Bancher-Todesca Dagmar
dc.contributor.author	Németh, László
dc.contributor.author	Igaz, Péter
dc.contributor.author	Rigó, János
dc.contributor.author	Sziller, István
dc.contributor.author	Kautzky-Willer Alexandra
dc.contributor.author	Somogyi, Anikó
dc.date.accessioned	2019-06-20T07:58:19Z
dc.date.available	2019-06-20T07:58:19Z
dc.date.issued	2018
dc.identifier	journalVolume=19;journalIssueNumber=12;journalTitle=INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES;pagerange=3734-3734;journalAbbreviatedTitle=INT J MOL SCI;
dc.identifier.citation	pagination=3734, 13 pages; journalVolume=19; journalIssueNumber=12; journalTitle=INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/6573
dc.identifier.uri	doi:10.3390/ijms19123734
dc.relation.ispartof	urn:issn:1661-6596 1422-0067
dc.title	The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
dc.type	Journal Article
dc.date.updated	2018-11-29T23:49:40Z
dc.rights.holder	NULL
dc.identifier.mtmt	30325428
dc.contributor.department	SE/AOK/K/Szülészeti és Nőgyógyászati Klinika
dc.contributor.institution	MTA-SE Molekuláris Medicina Kutatócsoport (2006-ig: MTA-SE Gastroenterológiai és Endocrinológiai Kutatócsoport)
dc.contributor.institution	II. Sz. Belgyógyászati Klinika